Lilly Mark
Impact in
- Sensory Systems top 2%
- Ion Channels and Receptors
- Pharmacology top 1%
- Cannabis and Cannabinoid Research
Papers in
-
- Ion channel regulation and function 3
- Cancer therapeutics and mechanisms 3
- Pharmacological Receptor Mechanisms and Effects 3
-
- Antimicrobial Resistance in Staphylococcus 6
- Co-authors
- James Harrison (4 shared papers)Garth T. Whiteside (10 shared papers)Katharine Walker (3 shared papers)Kenneth J. Valenzano (3 shared papers)Michelle Pearson (5 shared papers)Susan L. Gottshall (4 shared papers)Jamie Boulet (3 shared papers)James D. Pomonis (3 shared papers)
- Journals
- Journal of Pharmacology and Experimental Therapeutics (3 papers)Antimicrobial Agents and Chemotherapy (3 papers)Journal of Medicinal Chemistry (2 papers)Neuropharmacology (2 papers)Biochemical Pharmacology (1 paper)
- Partner nations
- United StatesCanadaJapan
In The Last Decade
Lilly Mark
19 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 90
- Sensory Systems 187
- Pharmacology 531
- Molecular Medicine 135
- Cellular and Molecular Neuroscience 401
- Toxicology 65
Countries citing papers authored by Lilly Mark
This map shows the geographic impact of Lilly Mark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lilly Mark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lilly Mark more than expected).
Fields of papers citing papers by Lilly Mark
This network shows the impact of papers produced by Lilly Mark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lilly Mark. The network helps show where Lilly Mark may publish in the future.
Co-authors
The 25 scholars most cited alongside Lilly Mark, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 233 | |
| 2 | 2003 | 213 | |
| 3 | 2010 | 183 | |
| 4 | 2004 | 137 | |
| 5 | 2010 | 108 | |
| 6 | 2015 | 103 | |
| 7 | 2007 | 101 | |
| 8 | 2005 | 75 | |
| 9 | 2013 | 54 | |
| 10 | 2013 | 45 | |
| 11 | 2016 | 41 | |
| 12 | 2010 | 39 | |
| 13 | 2006 | 27 | |
| 14 | 2004 | 21 | |
| 15 | 2009 | 21 | |
| 16 | 2023 | 11 | |
| 17 | 2023 | 9 | |
| 18 | 2011 | 8 | |
| 19 | 2022 | 7 |
About Lilly Mark
Lilly Mark is a scholar working on Molecular Biology, Infectious Diseases, Pharmacology, Cellular and Molecular Neuroscience and Physiology, having authored 19 papers that have together received 1.4k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (6 papers), Pain Mechanisms and Treatments (5 papers), Neuroscience and Neuropharmacology Research (3 papers), Cannabis and Cannabinoid Research (3 papers), Antibiotic Resistance in Bacteria (3 papers), Ion channel regulation and function (3 papers), Cancer therapeutics and mechanisms (3 papers) and Pharmacological Receptor Mechanisms and Effects (3 papers). The work is most often cited by research in Sensory Systems (187 citations), Pharmacology (531 citations), Molecular Medicine (135 citations), Cellular and Molecular Neuroscience (401 citations) and Toxicology (65 citations). Lilly Mark has collaborated with scholars based in United States, Canada and Japan. Frequent co-authors include James Harrison, Garth T. Whiteside, Katharine Walker, Kenneth J. Valenzano, Michelle Pearson, Susan L. Gottshall, Jamie Boulet, James D. Pomonis, Malvika Kaul and Edmond J. LaVoie. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Antimicrobial Agents and Chemotherapy, Journal of Medicinal Chemistry, Neuropharmacology and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.